Therefore, based on the results of our analysis, we suggest that it is helpful to identify candidate thyroid cancer patients with a poor prognosis to selectively perform the TERT gene mutation test in more advanced patients rather than in all patients. This evidence concerns the gene TERT and thyroid gland carcinoma.